'Heart in a Box': Global Effort Works to Put the Pieces Together

Graphic: Marlene J. Viola Some say it takes a village to raise a child. Michael V. Sefton proposes that it will take a world to build a heart. Sefton, a University of Toronto chemical engineering professor, leads an international effort called the Living Implants from Engineering (L.I.F.E.) Initiative, whose goal is to create a bioengineered heart in 10 years. To meet that mark, participants must grapple with a host of scientific concerns and more mundane matters. Research questions that must b

Written byPaul Smaglik
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Graphic: Marlene J. Viola
Some say it takes a village to raise a child. Michael V. Sefton proposes that it will take a world to build a heart. Sefton, a University of Toronto chemical engineering professor, leads an international effort called the Living Implants from Engineering (L.I.F.E.) Initiative, whose goal is to create a bioengineered heart in 10 years. To meet that mark, participants must grapple with a host of scientific concerns and more mundane matters. Research questions that must be resolved range from choosing between a natural and synthetic "scaffold" on which to graft the separately cultured parts to controlling cellular differentiation and vascular growth. Practical problems include divvying labor, finding funding, and negotiating intellectual property and spin-off company terms.

Although many scientific and practical issues remain unresolved, both science and practicality remain inextricably linked. The answer to each, Sefton believes, is communication and cooperation. Communication among partners will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies